The fixed 5:1 ratio means you cannot start low on one compound while ramping the other - if you raise retatrutide, cagrilintide goes up proportionally
Its crucial to discuss this combination with your healthcare provider to ensure its appropriate for your individual health situation and to receive guidance on managing any potential side effects
GLP-1 regulates blood glucose (sugar) levels by prompting the pancreas to release insulin
Key Takeaways Starting dose: 2.5 mg once weekly for 4 weeks (sub-therapeutic, intended for tolerability) Titration pace: Increase every 4 weeks: 2.5 5 7.5 10 12.5 15 mg Maintenance options: 5, 10, or 15 mg
(AD) SOD, Cat, GPx and GR specific activities, respectively
As scientists unravel the full range of GLP-1 receptor effects, patients suffering frequent, severe migraines might soon benefit from these versatile drugs